Back to top
Celvestrant 250 mg PFS
Celvestrant 250 mg PFS

Celvestrant 250 mg PFS

Celvestrant 250 mg PFS Specification

  • Salt Composition
  • Fulvestrant
  • Origin of Medicine
  • Synthetic
  • Pacakaging (Quantity Per Box)
  • 1 Pre-filled Syringe
  • Drug Type
  • Anticancer Drug
  • Ingredients
  • Fulvestrant 250 mg
  • Physical Form
  • Pre-filled Syringe (PFS)
  • Function
  • Hormonal Therapy for Breast Cancer
  • Recommended For
  • Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
  • Dosage
  • 250 mg administered intramuscularly
  • Dosage Guidelines
  • Administer 250 mg every two weeks for the first three doses followed by 250 mg once monthly thereafter
  • Suitable For
  • Adults specifically postmenopausal women
  • Quantity
  • 1 syringe per box
  • Storage Instructions
  • Store refrigerated at 2°C to 8°C (36°F to 46°F) do not freeze and protect from light
 
 

About Celvestrant 250 mg PFS



Celvestrant 250 mg PFS is a potent Anticancer Drug containing 250 mg of Fulvestrant in each Pre-filled Syringe (PFS). It is designed for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer. This synthetic medication is administered intramuscularly with a dosage of 250 mg every two weeks for the first three doses followed by 250 mg monthly. Each box contains 1 syringe and should be stored refrigerated at 2C to 8C, protected from light.

FAQs of Celvestrant 250 mg PFS:


Q: What is Celvestrant 250 mg PFS used for?

A: Celvestrant 250 mg PFS is used for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer.

Q: How should Celvestrant 250 mg PFS be stored?

A: Celvestrant 250 mg PFS should be stored refrigerated at 2C to 8C, and protected from light.

Q: What is the dosage recommendation for Celvestrant 250 mg PFS?

A: The recommended dosage is 250 mg administered intramuscularly every two weeks for the first three doses, followed by 250 mg monthly thereafter.

Q: Is Celvestrant 250 mg PFS suitable for all adults?

A: Celvestrant 250 mg PFS is specifically suitable for postmenopausal women.

Q: What is the salt composition of Celvestrant 250 mg PFS?

A: The salt composition of Celvestrant 250 mg PFS is Fulvestrant.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Tevadox 50 mg Injection

Tevadox 50 mg Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Used to treat bacterial infections, Other

Physical Form : Other, Injection

Storage Instructions : Store below 25C protect from light and moisture

Dosage Guidelines : Administered once or twice daily as directed by a healthcare professional

Origin of Medicine : Synthetic

Erlocip 100 mg Tablet

Erlocip 100 mg Tablet

Pacakaging (Quantity Per Box) : 10 x 1 tablet strips per box

Function : Used for the treatment of nonsmall cell lung cancer and pancreatic cancer, Other

Physical Form : Tablet, Other

Storage Instructions : Store in a cool and dry place away from direct sunlight and moisture

Dosage Guidelines : Take as directed by the oncologist; usually once daily before meals or as prescribed

Origin of Medicine : Synthetic

Neuzumab 150 mg Injection

Neuzumab 150 mg Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Other, To treat HER2positive breast and gastric cancers

Physical Form : Liquid

Storage Instructions : Store in a refrigerator at 2C to 8C. Do not freeze. Keep away from light.

Dosage Guidelines : Administered via intravenous infusion under medical supervision

Origin of Medicine : Biotechnologyderived

Acoxal 50 mg Injection

Acoxal 50 mg Injection

Pacakaging (Quantity Per Box) : 1 vial per box

Function : Treatment of bacterial infections, Other

Physical Form : Other, Injection

Storage Instructions : Store in a cool and dry place away from direct sunlight

Dosage Guidelines : To be administered as directed by a healthcare professional

Origin of Medicine : Allopathic